Cambridge's Seaside at Forefront of new approach to Fragile X

The Boston Globe
Date Published: 
August 23, 2010

The story of Matthew, a 9-year-old with Fragile X Syndrome, is one of the first patients on one of the first medications ever developed specifically to address the causes of an autism-like disorder. And — at least for him — it seems to be working.